Key terms
About MASI
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest MASI news
Apr 15
5:15am ET
Masimo upgraded to Buy from Hold at Stifel
Apr 15
4:55am ET
Buy Rating Affirmed for Masimo: Strategic Developments and Positive Outlook Signal Growth
Apr 08
2:14am ET
Apple Stock (NASDAQ:APPL) News: Here’s What Investors Need to Know
Apr 02
5:06am ET
Buy Rating Affirmed for Masimo Amid Strategic Split and Enhanced Profitability Outlook
Apr 01
8:27am ET
Masimo responds to Politan’s nominations, ‘refutes Politan’s false claims’
Mar 25
2:06pm ET
CEO tells WSJ Masimo may look at joint venture for consumer spilt
Mar 25
9:44am ET
Tesla downgraded, Disney upgraded: Wall Street’s top analyst calls
Mar 25
7:29am ET
Masimo price target raised to $166 from $145 at BTIG
Mar 25
7:17am ET
Masimo shareholder Politan nominates two independent candidates to board
Mar 25
6:50am ET
Analysts Conflicted on These Healthcare Names: Masimo (MASI), ImmunityBio (IBRX) and Madrigal Pharmaceuticals (MDGL)
Mar 25
6:48am ET
Masimo price target raised to $148 from $125 at Stifel
Mar 25
6:40am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amedisys (AMED) and Masimo (MASI)
Mar 25
5:30am ET
Analysts Offer Insights on Healthcare Companies: Esperion (ESPR) and Masimo (MASI)
Mar 25
5:12am ET
Masimo upgraded to Overweight from Equal Weight at Wells Fargo
Mar 24
7:21pm ET
Activist Politan planning second proxy battle at Masimo, WSJ reports
Mar 23
10:41am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Mar 22
4:13pm ET
Masimo Corp Contemplates Spinning Off Consumer Business
Mar 22
4:07pm ET
Masimo board approves evaluation of separation of consumer business
Feb 28
7:23am ET
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Masimo (MASI) and Johnson & Johnson (JNJ)
Feb 28
5:28am ET
Hold Rating on Masimo Amid Market Transition and Legal Uncertainties
Feb 28
5:20am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cytokinetics (CYTK), Alphatec Holdings (ATEC) and Masimo (MASI)
Feb 27
4:36pm ET
Masimo Corp: Financial Results Review and 2024 Outlook
Feb 27
4:08pm ET
Masimo sees FY24 adjusted EPS $3.44-$3.60, consensus $3.32
Feb 27
4:07pm ET
Masimo sees Q1 adjusted EPS 67c-74c, consensus 73c
Feb 27
4:07pm ET
Masimo reports Q4 adjusted EPS $1.25, consensus 87c
Feb 26
7:55am ET
Masimo (MASI) Gets a Hold from Piper Sandler
Feb 26
7:33am ET
Masimo price target raised to $117 from $70 at Piper Sandler
Feb 15
9:12am ET
Masimo Corp Announces Board Reshuffle and Director Resignation
Feb 07
5:29am ET
Hold Ratings Justified by Mixed Financial Signals and Market Challenges
Feb 01
1:28pm ET
What Wall Street experts are saying about Apple ahead of earnings
Feb 01
1:28pm ET
What Wall Street experts are saying about Apple ahead of earnings
MASI Financials
Key terms
Ad Feedback
MASI Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
MASI Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range